Unknown

Dataset Information

0

No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P-glycoprotein.


ABSTRACT: Hypericum perforatum L. (St. John's wort) is used to treat mild-to-moderate depression. Its potential safety risks are pharmacokinetic drug interactions via cytochrome P450 (CYP) enzymes and P-glycoprotein, presumably caused by hyperforin. In a phase I, open-label, nonrandomized, single-sequence study, the low-hyperforin Hypericum extract Ze 117 was investigated using a drug cocktail in 20 healthy volunteers. No pharmacokinetic interactions of Ze 117 were observed for CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP3A4, and P-glycoprotein. Area under the curve (AUC) and peak plasma concentration (Cmax ) of the used probe drugs showed 90% confidence intervals (CIs) of the geometric mean ratios of the drugs taken together with Ze 117 vs. probe drug alone, well within the predefined bioequivalence range of 80-125%. Though Ze 117 did not induce dextromethorphan metabolism by CYP2D6, it weakly increased dextromethorphan AUC ratio (mean 147.99, 95% CI 126.32-173.39) but not the corresponding metabolic ratio. Ze 117 does not show clinically relevant pharmacokinetic interactions with important CYPs and P-glycoprotein.

SUBMITTER: Zahner C 

PROVIDER: S-EPMC6766782 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P-glycoprotein.

Zahner Catherine C   Kruttschnitt Esther E   Uricher Julia J   Lissy Michael M   Hirsch Martin M   Nicolussi Simon S   Krähenbühl Stephan S   Drewe Jürgen J  

Clinical pharmacology and therapeutics 20190323 2


Hypericum perforatum L. (St. John's wort) is used to treat mild-to-moderate depression. Its potential safety risks are pharmacokinetic drug interactions via cytochrome P450 (CYP) enzymes and P-glycoprotein, presumably caused by hyperforin. In a phase I, open-label, nonrandomized, single-sequence study, the low-hyperforin Hypericum extract Ze 117 was investigated using a drug cocktail in 20 healthy volunteers. No pharmacokinetic interactions of Ze 117 were observed for CYP1A2, CYP2B6, CYP2C9, CYP  ...[more]

Similar Datasets

| S-EPMC6999061 | biostudies-literature
| S-EPMC2483264 | biostudies-literature
| S-EPMC7032678 | biostudies-literature
| S-EPMC9763113 | biostudies-literature
| S-EPMC7056460 | biostudies-literature
| S-EPMC8171068 | biostudies-literature
| S-EPMC6264782 | biostudies-literature
| S-EPMC11339956 | biostudies-literature
| S-EPMC8409492 | biostudies-literature
| S-EPMC6357942 | biostudies-literature